These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4846464)

  • 21. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 22. [A comparative study of fibrinogenolysis of adult and cord vein fibrinogen (author's transl)].
    Hafter R; Wallenstätter R; Graeff H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):175-8. PubMed ID: 6452398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the streptokinase-mediated activation of human plasminogen by fibrinogen and chloride ions.
    Chibber BA; Castellino FJ
    J Biol Chem; 1986 Apr; 261(12):5289-95. PubMed ID: 3957926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-exchange of streptokinase from anisoylated plasminogen streptokinase activator complex and other acylated streptokinase-plasminogen complexes.
    Smith RA
    Drugs; 1987; 33 Suppl 3():75-9. PubMed ID: 3315615
    [No Abstract]   [Full Text] [Related]  

  • 25. The binding of plasminogen, plasmin and streptokinase-plasminogen activator to fibrin [proceedings].
    Cederholm-Williams SA
    Biochem Soc Trans; 1977; 5(5):1441-3. PubMed ID: 144626
    [No Abstract]   [Full Text] [Related]  

  • 26. The streptokinase-human plasminogen activator complex. Composition and identity of a subcomponent with activator activity.
    Tomar RH; Taylor FB
    Biochem J; 1971 Dec; 125(3):793-802. PubMed ID: 5145901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanisms of the activation of plasminogen by streptokinase and urokinase.
    Takada Y; Takada A
    Adv Exp Med Biol; 1990; 281():223-34. PubMed ID: 2102613
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
    Tran-Thang C; Kruithof EK; Bachmann F
    J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci.
    Christner R; Li Z; Raeder R; Podbielski A; Boyle MD
    J Infect Dis; 1997 May; 175(5):1115-20. PubMed ID: 9129074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The purification of fibrinogen degradation products by pevikon block electrophoresis.
    Marder VJ; James HL; Sherry S
    Thromb Diath Haemorrh; 1969 Nov; 22(2):234-9. PubMed ID: 5380947
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelets and plasminogen activation.
    Loscalzo J; Pasche B; Ouimet H; Freedman JE
    Thromb Haemost; 1995 Jul; 74(1):291-3. PubMed ID: 8578474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex.
    Lin LF; Oeun S; Houng A; Reed GL
    Biochemistry; 1996 Dec; 35(51):16879-85. PubMed ID: 8988027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of active center formation in dog plasminogin by streptokinase and activity of a modified streptokinase.
    Reddy KN
    J Biol Chem; 1976 Nov; 251(21):6624-9. PubMed ID: 977590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limiting systemic plasminogenolysis reduces the bleeding potential for tissue-type plasminogen activators but not for streptokinase.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Wu DT; Refino CJ; Keyt BA; Bennett WF
    Thromb Haemost; 1996 Jun; 75(6):915-20. PubMed ID: 8822586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modification of the streptokinase functional groups during iodination].
    Nikandrov VN; Kaziuchits OA
    Vopr Med Khim; 1989; 35(1):41-7. PubMed ID: 2741398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of adenine nucleotides on the activator function of streptokinase].
    Nikandrov VN; Pyzhova NS; Votiakov VI
    Biull Eksp Biol Med; 1987 Jul; 104(7):49-51. PubMed ID: 3620649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The formation of an enzymically active complex between DFP-inhibited plasmin and streptokinase.
    Tomar RH; Beisswenger JG
    Proc Soc Exp Biol Med; 1973 May; 143(1):127-30. PubMed ID: 4267367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.